Sign In | Create an Account | Welcome, . My Account | Logout | Subscribe | Submit News | Contact Us | All Access E-Edition | Home RSS
 
 
 

FDA halts Amgen study after teen patient death

February 27, 2013
THE ASSOCIATED PRESS

WASHINGTON - Federal health regulators have halted Amgen's studies of its thyroid drug Sensipar after the death of a 14-year-old patient in a company trial.

 
 

 

I am looking for: